Novel method for treating chronic neuropathic pain with propofol derivatives
- 總結
- Gareth R. Tibbs, Ph.D.; Peter Goldstein, M.D.;Pamela Flood, M.D.
- 技術優勢
- Drug class demonstrated clinically to be safeNovel target for neuropathic painIn vivo demonstration of efficacyPatent information:Patent Pending (WO/2011/019747)
- 技術應用
- Neuropathic back painDiabetic neuropathyPost-herpetic neuralgiaHIV neuropathyTrigeminal neuralgia
- 詳細技術說明
- Lead Inventors: Gareth R. Tibbs, Ph.D.; Peter Goldstein, M.D.;Pamela Flood, M.D.
- *Abstract
-
None
- *Inquiry
- Cynthia LangColumbia Technology VenturesTel: (212) 854-8444Email: TechTransfer@columbia.edu
- *IR
- 2605
- *Principal Investigation
-
- *Publications
- G.R. Tibbs et al. HCN1 Channels as Targets for Anesthetic and Nonanesthetic Propofol Analogs in the Amelioration of Mechanical and Thermal Hyperalgesia in a Mouse Model of Neuropathic Pain, Vol. 345, Issue 3, June 2013, pp. 363-373.
- 國家/地區
- 美國
欲了解更多信息，請點擊 這裡
